investor relations - responsibilities >
   
 

 

 
 
 

David Wigley MBA
Director of Operations
and board member

Mr Wigley co-founder
NextGen Sciences

 
Mr Wigley has a wide range of project management, IT systems and manufacturing experience gained in companies including the Mars Corporation, Cambridge Systems Technology, as a manufacturing consultant, and in his role as operations director at Anglia Business Computers where he was a board member. Mr Wigley has extensive expertise in all aspects of operations and project planning relevant to NextGen Sciences' business and his expertise has enabled the company to take products from concept to design to production in the shortest possible times. Mr Wigley’s first degree is in Physics from the University of Nottingham. 

 

Kevin O’Donovan,
BSc, DipM, MBA
 
Kevin O’Donovan is a highly experienced director of life science companies with 23 years experience in the industry. From a sales and marketing background, gained within one of the largest independent life science distribution companies in the UK, Kevin went on to found his own company, Hybaid, specialising in Molecular Biology instrumentation.
Hybaid developed a number of innovative products and grew very rapidly reaching £7.3 million turnover and £1.3 million profit by 1994 with more than 80% of its manufacturing output exported. In that year, Kevin chose to sell Hybaid to a UK plc.
Kevin now works as a Business Angel within the Life Sciences market
 
 
Klaus Rosenau
Founder OAR
 
Mr. Rosenau has more than 21 years of experience in development and marketing of innovative technologies. He was engaged in the implementation and development of new technologies in a variety of leadership positions.In 1993, Mr Rosenau founded OAR Consulting GmbH and led his company to a successful IPO in 1998 and created an international operation supplying innovative solutions for information technology. He initiated several mergers and consequently improved the service spectrum of his company. In 2000 his success was honored with the award “finalist entrepreneur of the year”. Since 2003 he has supported IT-related companies in the development of their business strategy, financing and project planning.

 

 
     
  Note: The stock price performance shown on the quote above is not necessarily indicative of future price performance.  
     
 
investors homepage >
share information >
press releases >
regulatory news >
financials >
corporate
governance >
email alerts >
responsibilities >
 
   
 


 
   
 

For more information please contact>

James Heffernan

t: +44 (0) 1480 410 979
f: +44 (0) 1480 410 858
e: james.heffernan@nextgensciences.com